Background Recent studies underline the importance of cognitive reserve, which is supported by stress reduction, pleasure experience and meditation, for mental health. Mindfulness training is successfully applied to dementia and indicate a lasting positive effect on cognitive reserve, well‐being and motivation. The research project OpenSense investigated the potential of VR‐based intervention and assessment for dementia care in a proof‐of concept study. The VR‐based intervention was developed to foster mindfulness and sensory activation. Method VR‐based intervention was applied in persons with dementia (PwD) with Alzheimer’s dementia (AD; n=12, age M=85.0 years, MMSE M=21.5) and healthy controls (n=12, age M=75.1 years, MMSE M=30) using 30 minutes of panoramic video‐based multi‐sensory experiences presenting stimuli that empower relaxation (body‐scanning, beach, forest) and activation (bakery, orchestra). EEG‐based alpha‐band signals (8‐12 Hz) associated with relaxation and inhibitory control were recorded before, during and after intervention and eye tracking was applied during intervention. Result Pre‐post EEG analysis showed significant increases in alpha power and brain connectivity for PwD with AD and controls (post > pre, p<.05). EEG baseline alpha power demonstrated higher values for healthy controls than for PwD (AD). Eye movement analysis demonstrated significant differences between PwD (AD) and controls: eye blink rate AD > controls, p=.004(**) from the observation of a 3 minutes video, and significant correlation (Rho=.607, p=.003(**); 3 minutes video) was achieved between eye movements and the Freiburg Mindfulness Inventory score. Conclusion The potential of VR‐based intervention based on mindfulness and sensory activation is very promising: the study demonstrated significant increases of EEG alpha power and brain connectivity where PwD usually suffer from decline and gaze data acquired during intervention indicate potential for non‐invasive assessment for decision support. OpenSense anticipates numerous opportunities for novel VR‐based care services for empowering cognitive reserve, inducing sensory activation, raising awareness and motivation for self‐regulation, and as pervasive assessment tool.
Background Early experiences with different flavors play an important role in infant development, including food and taste acceptance. Flavors are already perceived in utero with the development of the taste and olfactory system and are passed on to the child through breast and bottle feeding. Therefore, the first 1000 days of life are considered a critical window for infant developmental programming. Objective The objective of our study is to investigate, both in the prenatal and postnatal period, taste sensitivity, preferences, and dietary diversity of mother-infant pairs. The explorative study design will also report on the impact of these variables on body composition (BC) and biomarkers. In contrast to conventional methods, this study involves long-term follow-up data collection from mother-infant pairs; moreover, the integration of audiovisual tools for recording infants' expressions pertaining to taste stimuli is a novelty of this study. Considering these new methodological approaches, the study aims to assess taste-related data in conjunction with BC parameters like fat-free mass or fat mass, biomarkers, and nutritional intake in infants and children. Methods Healthy pregnant women aged between 18 and 50 years (BMI≥18.5 kg/m2 to ≤30 kg/m2; <28 weeks of gestation) were recruited from January 2014 to October 2014. The explorative design implies 2 center visits during pregnancy (24-28 weeks of gestation and 32-34 weeks of gestation) and 2 center visits after delivery (6-8 weeks postpartum and 14-16 weeks postpartum) as well as follow-up visits at 1, 3-3.5, and 6 years after delivery. Data collection encompasses anthropometric and biochemical measurements as well as BC analyses with air displacement plethysmography, taste perception assessments, and multicomponent questionnaires on demographics, feeding practices, and nutritional and lifestyle behaviors. Audiovisual data from infants’ reactions to sensory stimuli are collected and coded by trained staff using Baby Facial Action Coding and the Body Action Posture System. Birth outcomes and weight development are obtained from medical records, and additional qualitative data are gathered from 24 semistructured interviews. Results Our cohort represents a homogenous group of healthy women with stringent exclusion criteria. A total of 54 women met the eligibility criteria, whereas 47 mother-child pairs completed data collection at 4 center visits during and after pregnancy. Follow-up phases, data analyses, and dissemination of the findings are scheduled for the end of 2023. The study was approved by the ethics committee of the Medical University of Graz (EC No 26–066 ex 13/14), and all participants provided informed consent. Conclusions The results of this study could be useful for elucidating the connections between maternal and infant statuses regarding diet, taste, biomarkers, and prenatal and postnatal weight development. This study may also be relevant to the establishment of further diagnostic and interventional strategies targeting childhood obesity and early body fat development. International Registered Report Identifier (IRRID) DERR1-10.2196/37279
Background Early detection of cognitive impairment can slow progression to dementia when using appropriate therapy. For early detection of dementia dual task combining cognitive tasks and walking might be suitable, since individuals with cognitive impairment have shown greater changes in gait specific parameters on dual task test (DT) compared to single task test (ST). This study investigates whether these changes correlate with poorer cognitive function in healthy older adults. Methods In a cross-sectional study 174 healthy adults (66,48±4,26years; 40%female) completed the Cognitive Functions Dementia Test (CFD), with a lower CFD index indicating lower cognitive function. Participants performed ST (walking 20m) and DT (walking 20m & counting backwards), in which step frequency, stride length and gait speed were monitored by Pablo sensors. Cognitive cost (CC) was determined for each gait variable. CC represents a change score between SD & DT and quantifies cognitive demands, with higher CC indicating poorer cognitive function. Pearson correlations and stepwise linear regression adjusted for age and gender were applied to analyze the association between CFD Index (dependent variable) and CC gate variables (predictors) (α = 5%). Results Significant correlations were observed between CFD Index and CC step frequency (p=.014, r=-.187), CC stride length (p=.037, r=-.160) and CC gait speed (p=.002, r=-.232). Since gait variables were intercorrelated (multicollinearity), only gait speed was significant predictor for CFD Index (ß = -.243, p<.001, R2 = .053) in a stepwise adjusted regression model. Conclusions Changes in gait speed might be sensitive enough to indicate differences of cognitive performance among older individuals. Therefore, DT could be included in screening procedures as alert for potential cognitive decline. Key messages
Background The early diagnosis of cognitive impairments is an important step in the adequate management of dementia. The project “Smart Cognition & Behaviour Screening powered by Augmented Reality” (SCOBES-AR) aims to develop a multimodal screening tool (MST) for the early detection of cognitive impairments using augmented and virtual reality. The first project phase selected validated assessments for combination with the MST and tested it in 300 healthy older adults. Objective This study established a protocol for the implementation and usability of a mixed reality (MR)–enhanced multidisciplinary screening tool for the early detection of cognitive impairments in older adults. The developed MST will be partially enhanced by MR, which is a combination of augmented reality (AR) and virtual reality (VR). This MR-enhanced prototype of the screening tool (MR-MST) will be tested and compared to the previously developed MST. The usability of the prototype will also be examined. Methods This single-center observational crossover design study screens 100 healthy participants (aged 60-75 years) for cognitive decline using a specially developed MST (assessment of cognitive functions, olfactory sensitivity, nutritional preferences, gait parameters, reaction times, and activities of daily living) and an MR-enhanced MST in which the assessments of cognitive functions, reaction time, activities of daily living, and gait will be performed using tailor-made software and AR and VR hardware. The results of the MR-enhanced MST will be compared to those without MR. The usability of the developed MR-enhanced MST will be tested on 10 investigators and 10 test participants using observed summative evaluation and the codiscovery method, and on 2 usability experts using the codiscovery and cognitive walkthrough methods. Results This study was funded by the Austrian Research Promotion Agency (grant 866873) and received approval from the ethics committee of the Medical University of Graz. The MR-MST and the experimental protocol for this study were developed. All participants gave written informed consent. As of July 15, 2022, a total of 70 participants have been screened. Data analysis and dissemination are scheduled for completion by September 2023. Conclusions The development and testing of the MR-MST is an important step toward the establishment of the best practice procedure for the implementation of AR and VR in the screening of cognitive declines in older adults. It will help improve our knowledge of the usability and applicability of the developed prototype and promote further advancement in AR and VR technologies to be used in therapeutic settings. International Registered Report Identifier (IRRID) DERR1-10.2196/39513
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.